Ovarian Cancer Trial, Recruiting NCT06611072 Sponsor: Gynaecologisch Oncologisch Centrum Zuid Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT06611072
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are at least 18 years old and are mentally competent to participate
  • People who have been newly diagnosed with ovarian cancer and are scheduled for primary surgery to remove as much of the cancer as possible, or people with ovarian cancer scheduled for a planned surgery after initial treatment
  • People without ovarian cancer who are having surgery for a non-cancerous gynaecological condition under general anaesthetic (as a comparison group)

Who may not be able to join:

  • People who are not mentally competent to participate
  • People who are pregnant or breastfeeding
  • People who have a known inflammatory or infectious disease, or a weakened immune system
  • People taking medications that affect how the immune system works
  • People with serious other health conditions, including another active cancer (other than certain minor skin cancers or early-stage cancers that have not spread)
  • People with serious psychiatric conditions
  • People who report drinking more than 21 units of alcohol per week

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 00310402399300

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Gynaecologisch Oncologisch Centrum Zuid
Registry
ClinicalTrials.gov
Start date
1 January 2025
Est. completion
1 October 2027

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Cell composition of immune organs using flow cytometry; Cell composition and epigenetic status of cells of immune organs using ATAC and RNA sequencing; Trained immunity response

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov